Viswanathan, Thiruselvam http://orcid.org/0000-0001-9817-6730
Misra, Anurag
Chan, Siu-Hong http://orcid.org/0000-0002-9554-7273
Qi, Shan http://orcid.org/0000-0003-0175-6267
Dai, Nan http://orcid.org/0000-0003-3268-1835
Arya, Shailee http://orcid.org/0000-0002-7689-7411
Martinez-Sobrido, Luis http://orcid.org/0000-0001-7084-0804
Gupta, Yogesh K. http://orcid.org/0000-0001-6372-5007
Article History
Received: 9 March 2021
Accepted: 6 May 2021
First Online: 2 June 2021
Competing interests
: Y.K.G. is the founder of Atomic Therapeutics. S-H.C. and N.D. are employees of New England Biolabs, a manufacturer and vendor of molecular biology reagents, including vaccinia RNA capping enzyme and cap 2′-<i>O</i> methyltransferase. None of these affiliations affect the authors’ impartiality, adherence to journal standards and policies, or availability of data. All other co-authors declare no competing interests.